Streamline Health Solutions (STRM) has released an update to notify the public and investors about its officers.
On February 5, 2024, a company expanded its board to seven members, welcoming seasoned investors Benjamin L. Stilwill and Matthew W. Etheridge, with Etheridge bringing over two decades of experience in investment management, notably in healthcare and IT. Alongside his directorship, Etheridge has been granted $167,000 in restricted stock and cash, and both he and Stilwill are slated to receive expense reimbursements. Their appointments are effective from the closure of a Debt Private Placement on February 7, 2024, and neither has any reported familial ties or material interests that could present conflicts of interest within the company.
For further insights into STRM corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
